Sickle Cell Disease and Bone Marrow Transplant in Ethiopia
A genetic blood condition called sickle-cell disease damages the hemoglobin in red blood cells. Sickle cell disease (SCD), which can affect up to 3% of births nationwide, is widespread throughout Ethiopia. Nevertheless, many health ministries continue to place little importance on it, but now the government is taking initiatives to tackle the diseases. However, SCD has a variety of negative impacts, including increased morbidity and mortality, a decline in quality of life, and a significant socioeconomic burden on individuals, families, and healthcare systems. This post will tell you about Sickle Cell Disease in Ethiopia and how it is treated with a bone marrow transplant.
According to experts, the number of Sickle cell disease patients will rise over the following several decades. Health outcomes for those with SCD have significantly improved in Ethiopia. But for many patients, Sickle cell disease problems reduce opportunities and degrade their quality of life. The lives of those who have Sickle cell disease can be improved by increasing access to care and lowering treatment expenses. In addition, bone marrow transplant facilities should be provided quickly in the country as the chance of getting cured of Sickle cell disease is more by BMT.